NLRP3 and idiopathic pulmonary fibrosis: Our RNA-seq analysis results and the consistency with our in vitro and in vivo signaling pathway experiments provide evidence for the involvement of the NOX4/NLRP3/p38 MAPK signaling pathway in the therapeutic effect of AS_LIG@PPGC NPs on IPF.